Study S001282

Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06009653
Acronym: TRZ
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: WITHDRAWN
Enrollment: 0
Start: 2023-09-13
Primary completion: 2024-05-29
Lead sponsor: Washington University School of Medicine
Conditions: Obesity; Metabolic Disease
Interventions: BEHAVIORAL:Standard Care; BEHAVIORAL:Culturally-tailored dietary and behavioral intensive lifestyle intervention; DRUG:Placebo; DRUG:Tirzepatide
Results posted: FALSE
Secondary identifiers: NIH:P50MD017344

Registered primary outcomes

Change in body weight [After 24 weeks of intervention]
Change in body weight [After 52 weeks of intervention]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.